255 related articles for article (PubMed ID: 32161056)
1. Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors.
Wadström H; Pettersson A; Smedby KE; Askling J
Ann Rheum Dis; 2020 May; 79(5):581-586. PubMed ID: 32161056
[TBL] [Abstract][Full Text] [Related]
2. Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.
Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
Arthritis Rheum; 2010 May; 62(5):1252-8. PubMed ID: 20155827
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer.
He W; Fang F; Varnum C; Eriksson M; Hall P; Czene K
J Clin Oncol; 2015 Jul; 33(20):2262-9. PubMed ID: 26033800
[TBL] [Abstract][Full Text] [Related]
4. TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study.
Raaschou P; Frisell T; Askling J;
Ann Rheum Dis; 2015 Dec; 74(12):2137-43. PubMed ID: 25107559
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group.
J Natl Cancer Inst; 1996 Nov; 88(21):1543-9. PubMed ID: 8901852
[TBL] [Abstract][Full Text] [Related]
6. Association of aromatase inhibitors with coronary heart disease in women with early breast cancer.
Seruga B; Zadnik V; Kuhar CG; Marinko T; Cufer T; Zakotnik B; Zorman D; Ocana A; Amir E
Cancer Invest; 2014 May; 32(4):99-104. PubMed ID: 24548302
[TBL] [Abstract][Full Text] [Related]
7. Stroke risk and tamoxifen therapy for breast cancer.
Geiger AM; Fischberg GM; Chen W; Bernstein L
J Natl Cancer Inst; 2004 Oct; 96(20):1528-36. PubMed ID: 15494603
[TBL] [Abstract][Full Text] [Related]
8. Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen.
McCaskill-Stevens W; Wilson J; Bryant J; Mamounas E; Garvey L; James J; Cronin W; Wickerham DL
J Natl Cancer Inst; 2004 Dec; 96(23):1762-9. PubMed ID: 15572758
[TBL] [Abstract][Full Text] [Related]
9. Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer.
Chien AJ; Duralde E; Hwang R; Tsung K; Kao CN; Rugo HS; Melisko ME; Esserman LJ; Munster PN; Cedars M; Kerlikowske K; McCulloch CE; Rosen MP
Breast Cancer Res Treat; 2015 Aug; 153(1):173-81. PubMed ID: 26208485
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.
Raaschou P; Simard JF; Holmqvist M; Askling J;
BMJ; 2013 Apr; 346():f1939. PubMed ID: 23568792
[TBL] [Abstract][Full Text] [Related]
11. Hormonal therapy for breast cancer and diabetes incidence among postmenopausal women.
Santorelli ML; Hirshfield KM; Steinberg MB; Rhoads GG; Lin Y; Demissie K
Ann Epidemiol; 2016 Jun; 26(6):436-40. PubMed ID: 27157863
[TBL] [Abstract][Full Text] [Related]
12. No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.
Holmqvist ME; Wedrén S; Jacobsson LT; Klareskog L; Nyberg F; Rantapää-Dahlqvist S; Alfredsson L; Askling J
Arthritis Rheum; 2009 Oct; 60(10):2861-9. PubMed ID: 19790058
[TBL] [Abstract][Full Text] [Related]
13. Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis.
Holmqvist M; Gränsmark E; Mantel A; Alfredsson L; Jacobsson LT; Wallberg-Jonsson S; Askling J
Ann Rheum Dis; 2013 Apr; 72(4):541-6. PubMed ID: 22610975
[TBL] [Abstract][Full Text] [Related]
14. Children Born by Women With Rheumatoid Arthritis and Increased Susceptibility for Chronic Diseases: A Nationwide Cohort Study.
Jølving LR; Nielsen J; Kesmodel US; Nielsen RG; Beck-Nielsen SS; Nørgård BM
Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1192-1197. PubMed ID: 29226569
[TBL] [Abstract][Full Text] [Related]
15. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
Bradbury BD; Lash TL; Kaye JA; Jick SS
Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
[TBL] [Abstract][Full Text] [Related]
17. The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer.
Abdel-Qadir H; Amir E; Fischer HD; Fu L; Austin PC; Harvey PJ; Rochon PA; Lee DS; Anderson GM
Eur J Cancer; 2016 Nov; 68():11-21. PubMed ID: 27693889
[TBL] [Abstract][Full Text] [Related]
18. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
19. Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control study.
Hjorth CF; Nielsen AS; Sørensen HT; Lash TL; Damkier P; Hamilton-Dutoit S; Cronin-Fenton D
Acta Oncol; 2019 Feb; 58(2):168-174. PubMed ID: 30458661
[TBL] [Abstract][Full Text] [Related]
20. Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort study.
Westerlind H; Delcoigne B; Askling J
RMD Open; 2020 May; 6(1):. PubMed ID: 32423969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]